RenovoRx, Inc. (RNXT)
1.67
+0.19
(+12.84%)
USD |
NASDAQ |
Aug 28, 16:00
1.70
+0.03
(+1.80%)
After-Hours: 20:00
RenovoRx Market Cap : 75.35M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 75.35M |
| August 27, 2026 | 66.78M |
| August 26, 2026 | 67.23M |
| August 25, 2026 | 64.07M |
| August 24, 2026 | 56.40M |
| August 21, 2026 | 59.56M |
| August 20, 2026 | 59.56M |
| August 19, 2026 | 59.34M |
| August 18, 2026 | 52.79M |
| August 17, 2026 | 54.15M |
| August 14, 2026 | 63.17M |
| August 13, 2026 | 56.85M |
| August 12, 2026 | 50.54M |
| August 11, 2026 | 51.89M |
| August 10, 2026 | 52.34M |
| August 07, 2026 | 50.46M |
| August 06, 2026 | 51.81M |
| August 05, 2026 | 47.76M |
| August 04, 2026 | 46.85M |
| August 03, 2026 | 47.76M |
| July 31, 2026 | 43.17M |
| July 30, 2026 | 42.40M |
| July 29, 2026 | 40.46M |
| July 28, 2026 | 40.88M |
| July 27, 2026 | 43.48M |
| Date | Value |
|---|---|
| July 24, 2026 | 38.98M |
| July 23, 2026 | 38.50M |
| July 22, 2026 | 38.99M |
| July 21, 2026 | 39.54M |
| July 20, 2026 | 38.91M |
| July 17, 2026 | 38.98M |
| July 16, 2026 | 39.69M |
| July 15, 2026 | 38.73M |
| July 14, 2026 | 38.29M |
| July 13, 2026 | 41.15M |
| July 10, 2026 | 41.90M |
| July 09, 2026 | 42.34M |
| July 08, 2026 | 40.55M |
| July 07, 2026 | 41.79M |
| July 06, 2026 | 42.69M |
| July 02, 2026 | 41.45M |
| July 01, 2026 | 43.03M |
| June 30, 2026 | 44.15M |
| June 29, 2026 | 43.70M |
| June 26, 2026 | 42.52M |
| June 25, 2026 | 41.90M |
| June 24, 2026 | 42.94M |
| June 23, 2026 | 41.03M |
| June 22, 2026 | 41.01M |
| June 18, 2026 | 41.45M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Enanta Pharmaceuticals, Inc. | 396.03M |
| Travere Therapeutics, Inc. | 6.184B |
| REGENXBIO, Inc. | 523.22M |
| Krystal Biotech, Inc. | 10.40B |
| ACADIA Pharmaceuticals, Inc. | 5.011B |
Market Cap Related Metrics
| PS Ratio | 33.51 |
| Price to Book Value | 8.392 |
| Price | 1.67 |
| Earnings Yield | -18.80% |